Risk factors and long-term evolution of thyroid dysfunction during repeated antiviral treatments in 221 patients with chronic hepatitis C

被引：0
作者：
Moncoucy, X
Leymarie, F
Levy, S
Bernard-Chabert, B
Jolly, D
Delemer, B
Cadiot, G
Diebold, MD
Thiefin, G
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [1] Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C
    Moncoucy, X
    Leymarie, F
    Delemer, B
    Lévy, S
    Bernard-Chabert, B
    Bouché, O
    Jolly, D
    Diebold, MD
    Cadiot, G
    Thiéfin, G
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (04): : 339 - 345
  • [2] Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
    Chang, Yu-Kang
    Tseng, Yuan-Tsung
    Chen, Kou-Huang
    Chen, Kow-Tong
    BMC ENDOCRINE DISORDERS, 2019, 19 (1)
  • [3] Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
    Yu-Kang Chang
    Yuan-Tsung Tseng
    Kou-Huang Chen
    Kow-Tong Chen
    BMC Endocrine Disorders, 19
  • [4] Thyroid Dysfunction and Long-term Outcome during and after Interferon-alpha Therapy in Patients with Chronic Hepatitis C
    Themistoklis, Vasiliadis
    Panagiotis, Anagnostis
    Georgios, Nalmpantidis
    Konstantinos, Soufleris
    Kaliopi, Patsiaoura
    Nikolaos, Grammatikos
    Eleni, Orfanou-Koumerkeridou
    Konstantinos, Kargiotis
    Aristidis, Slavakis
    Aristidis, Deliyiannidis
    Nikolaos, Eugenidis
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2011, 40 (09) : 394 - 400
  • [5] Thyroid Dysfunction in Chinese Patients With Chronic Hepatitis C Treated With Interferon Alpha: Incidence, Long-Term Outcomes and Predictive Factors
    Yan, Zehui
    Fan, Ke
    Fan, Yi
    Wang, Xiaohong
    Mao, Qing
    Deng, Guohong
    Wang, Yuming
    HEPATITIS MONTHLY, 2012, 12 (09)
  • [6] Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
    Hwang, Yong
    Kim, Won
    Kwon, So Young
    Yu, Hyung Min
    Kim, Jeong Han
    Choe, Won Hyeok
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (06) : 792 - 800
  • [7] Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: Morphometric analysis of repeated biopsies
    Kage, M
    Shimamatu, K
    Nakashima, E
    Kojiro, M
    Inoue, O
    Yano, M
    HEPATOLOGY, 1997, 25 (04) : 1028 - 1031
  • [8] Thyroid Dysfunction in Antiviral Therapy of Chronic Hepatitis C
    Dabrowska, Magdalena M.
    Panasiuk, Anatol
    Flisiak, Robert
    HEPATO-GASTROENTEROLOGY, 2010, 57 (101) : 826 - 831
  • [9] The long-term pathological evolution of chronic hepatitis C
    Yano, M
    Kumada, H
    Kage, M
    Ikeda, K
    Shimamatsu, K
    Inoue, O
    Hashimoto, E
    Lefkowitch, JH
    Ludwig, J
    Okuda, K
    HEPATOLOGY, 1996, 23 (06) : 1334 - 1340
  • [10] ANTIVIRAL THERAPY FOR THE PREVENTION OF LONG-TERM CIRRHOSIS RISK IN PATIENTS WITH CHRONIC HEPATITIS B
    Yang, H. -I.
    Hoang, J.
    Lin, D.
    Liu, J.
    Hu, H. -H.
    Lee, M. -H.
    Nguyen, N. H.
    Kim, Y.
    Jen, C. -L.
    Vu, V.
    Le, A.
    Chaung, K.
    Nguyen, V.
    Trinh, H.
    Li, J.
    Zhang, J.
    Hsing, A.
    Chen, C. -J.
    Nguyen, M. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S591 - S591
12345